Catherine Genestie

6PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersReproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 08, 2026
ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial.

Félix Blanc-Durand, Catherine Genestie, Sergey Nikolaev

|Apr 26, 2024
Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy.

Elisa Yaniz-Galende, Qinghe Zeng, Juan F Bejar-Grau

|Oct 02, 2023
Factors associated with the collection of isolated immature oocytes during ovarian tissue cryopreservation.

Marie Prades, Flora Marzouk, Benoit Schubert

|Sep 27, 2023
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.

Raphaël Leman, Etienne Muller, Angelina Legros

|Jul 29, 2023
Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer.

Edith Borcoman, Elizabeth Santana Dos Santos, Catherine Genestie

|Apr 17, 2023
Clinical Relevance of BRCA1 Promoter Methylation Testing in Patients with Ovarian Cancer.

Félix Blanc-Durand, Roseline Tang, Margaux Pommier

Pageof 1